2023-05-05 21:16:35
If there is something that is constantly evolving, it is health research, and the issue that has currently attracted the greatest interest in this area is the so-called Precision Medicinewhich beyond an innovative idea, entails necessary changes to increase people’s quality of life.
Basically, with the help of technology and new knowledge, the Precision Medicine investigates the biological basis of diseases to support the development of innovative targeted therapies.
And in a deeper way, it contributes to a comprehensive treatment, focused on each case as a whole, integrating biological, environmental, ethnic, gender information, among other factors, thus completing a more accurate picture or diagnosis, which only a doctor can determine. .
Getting back to the basic
The importance of genetics in health is not new. It is what makes us unique, it contains the information we inherit and is useful for detecting the possibility of future diseases that can be prevented thanks to Precision Medicinewhich uses our data on genes, proteins, carbohydrates, molecules and other substances typical of the human body as a tool to detect the target points that guide the search for specific personalized therapies.
The best news is that the Precision Medicine it can be a therapeutic alternative to treat different conditions, including those of genetic origin, such as diabetes, obesity and depression, not to mention the advances that are already glimpsed in oncology. This is a sophisticated process, but one that human beings deserve.
How does it work?
Through biomarkers (biological indicators), Precision Medicine classifies the genotype and phenotype of each person to determine their risk of suffering from certain diseases and/or their response to treatments, in addition to defining outcome measures and assessment criteria for the most accurate clinical research.
They may include, for example, cognitive tests in the form of tablet games, mood and disease progression using voice recording and actigraphy, among other measures.
Lung biomarkers
Since 2020, through an alliance with the Mexican Association of Pharmaceutical Research Industries, Pfizer joined the Lung Biomarkers Program with 5 other laboratories in the country.
Thanks to this, many people will be able to benefit from the action of biomarkers (biological indicators) that determine the specific mutation of their condition, with an accurate diagnosis that only a doctor can define, through high-quality technology that personalizes their treatment and, consequently, maintain their quality of life.
In addition to this action, Pfizer has committed to exploring genetic, phenotypic and functional biomarkers to help guide clinical research strategies, developing medicines and vaccines with potentially transformative results.
Consult your doctor – GCMA CODE
Do not miss:
Jaw problems? Science in Mexico has the alternative
What prevents nuclear weapons from accidentally detonating?
1683345708
#Precision #Medicine #health #needed
